MWAM

Manhattan West Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$333K	Buy	+6,843	New	+$333K	0.08%	111
2024 Q1	–	Sell	-3,442	Closed	-$215K	–	150
2023 Q4	$215K	Buy	+3,442	New	+$215K	0.06%	130